• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.820 -0.530 (-22.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,159,077
Open 1.960
Bid (Size) 1.810 (100)
Ask (Size) 1.830 (100)
Prev. Close 2.350
Today's Range 1.710 - 1.960
52wk Range 0.5606 - 13.25
Shares Outstanding 596,978
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are experiencing notable movement on Friday? ↗
Today 15:00 EDT
Via Chartmill
These stocks have an unusual volume in today's session ↗
Today 13:00 EDT
Via Chartmill

Performance

YTD
-50.4%
-50.4%
1 Month
-9.0%
-9.0%
3 Month
-55.4%
-55.4%
6 Month
+130.9%
+130.9%
1 Year
+48.0%
+48.0%

More News

Read More
Friday's session: top gainers and losers ↗
Today 12:30 EDT
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Today 10:30 EDT
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Today 8:30 EDT
Via Chartmill
News headline image
Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates
March 31, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
March 27, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Registration of Five Trademarks
March 18, 2026
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Enveric Biosciences Announces Withdrawal Of Petition Against Its Patent — ENVB Stock Rises ↗
February 25, 2026
Via Stocktwits
Topics Intellectual Property
News headline image
Enveric Biosciences Announces Withdrawal of Petition Against Its Patent
February 25, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data
February 19, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
January 29, 2026
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
January 28, 2026
From Enveric Biosciences, Inc.
Via Business Wire
Top movers analysis in the middle of the day on 2026-01-28: top gainers and losers in today's session. ↗
January 28, 2026
Via Chartmill
Gapping stocks in Wednesday's session ↗
January 28, 2026
Via Chartmill
News headline image
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
January 28, 2026
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Why Is ENVB Stock Rising Today? ↗
December 29, 2025
Via Stocktwits
Topics Intellectual Property
News headline image
Enveric Biosciences Announces Patent Issuance
December 29, 2025
From Enveric Biosciences
Via Business Wire
News headline image
The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub
December 23, 2025
Via MarketMinute
Topics Economy Initial Public Offering
News headline image
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
December 12, 2025
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Top movers analysis one hour before the close of the markets on 2025-12-11: top gainers and losers in today's session. ↗
December 11, 2025
Via Chartmill
News headline image
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
December 11, 2025
From Enveric Biosciences, Inc
Via Business Wire
News headline image
These stocks are moving in today's session ↗
December 10, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
December 10, 2025
Via Chartmill
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
December 10, 2025
Via Chartmill

Frequently Asked Questions

Is Enveric Biosciences, Inc. - Common Stock publicly traded?
Yes, Enveric Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Enveric Biosciences, Inc. - Common Stock trade on?
Enveric Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enveric Biosciences, Inc. - Common Stock?
The ticker symbol for Enveric Biosciences, Inc. - Common Stock is ENVB on the Nasdaq Stock Market
What is the current price of Enveric Biosciences, Inc. - Common Stock?
The current price of Enveric Biosciences, Inc. - Common Stock is 1.820
When was Enveric Biosciences, Inc. - Common Stock last traded?
The last trade of Enveric Biosciences, Inc. - Common Stock was at 04/17/26 04:00 PM ET
What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?
The market capitalization of Enveric Biosciences, Inc. - Common Stock is 1.09M
How many shares of Enveric Biosciences, Inc. - Common Stock are outstanding?
Enveric Biosciences, Inc. - Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap